Skip to content

INDIVIDUALIZED HOMOEOPATHIC MEDICINES FOR OA KNEE JOINT.

EFFICACY OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN 50-MILLESIMAL POTENCY IN PERI AND POST MENOPAUSAL WOMEN SUFFERING FROM OSTEOARTHRITIS OF KNEE WITH ITS MIASMATIC ANALYSIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/105019
Enrollment
167
Registered
2026-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Individualized Homoeopathic Medicines In 50- Millesimal Potency: The intervention was planned as administering indicated homeopathic medicines in 50-millesimal potencies, as decided app

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female patients of peri and post-menopausal age suffering from osteoarthritis of knee joints (ICD-11 FA01.0 for primary, FA01.1 for post-traumatic, and FA01.2 for other secondary type) since last 3 months. 2.American College of Rheumatology 2019 diagnostic criteria of knee osteoarthritis using history, physical examination and radiographic findings pain in knee and one of the following-(a) age over 50 years, (b) morning stiffness less than 30 min, and (c) crepitus on active motion and osteophytes on x-ray.

Exclusion criteria

Exclusion criteria: 1.Severe degeneration of knee joint with mark joint narrowing, varus, or valgus deformity of knee; as evidenced by imaging or other evidences and requiring surgical intervention. 2.Self-reported joint disorders other than osteoarthritis (e.g., inflammatory joint disease, specific arthropathy, hyperuricemia and/or gout, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs). 3.Intra-articular injections within 2 weeks before study entry. 4.Transplanted knees. 5.Non ambulant patient. 6.Obese patient (body mass index 30.0 or more). 7.Recent significant knee surgery within last 6 months. 8.Vulnerable population - unconscious, ambulatory, too seek for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 9.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 10.Pregnant and puerperal women, lactating mothers. 11.Severe osteoporosis and already diagnosed case of osteoarthritis of knee joint.

Design outcomes

Primary

MeasureTime frame
Knee injury and osteoarthritis outcome score (KOOS)Timepoint: At baseline, every month, up to 3 months

Secondary

MeasureTime frame
EQ-5D-5L questionnaireTimepoint: At baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactDr Jayabrata Pal

The Calcutta Homoeopathic Medical College and Hospital

dr.jayabratapal@gmail.com7679752020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026